Borrelia gene products critical for natural infection cycle
疏螺旋体基因产物对自然感染周期至关重要
基本信息
- 批准号:10659166
- 负责人:
- 金额:$ 48.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Amino AcidsAnti-Infective AgentsAntibiotic TherapyAntigensArthropod VectorsBacteriaBindingBiologicalBiological ProductsBiologyBlack-legged TickBorreliaBorrelia burgdorferiBorrelia burgdorferi GroupC-terminalCellsChronicClinicalComplexCrystallizationDevelopmentDimensionsEarly DiagnosisEpitopesEuropeEventGenomeGoalsHigh temperature of physical objectHumanImpairmentInfectionInfection ControlInvestigationIxodesKnowledgeLengthLyme DiseaseMammalsMeasuresMediatingMembraneMembrane ProteinsMolecular ChaperonesN-terminalNatureOrder SpirochaetalesPathogenesisPeptide HydrolasesPeptidoglycanPharmaceutical PreparationsPhasePost Treatment Lyme Disease SyndromeProcessProtein InhibitionProteinsProteolytic ProcessingRecombinantsRelapseRodentRoleSeriesSpirochaetales InfectionsStructureSymptomsTherapeuticTick InfestationsTick-Borne InfectionsTicksTranslation ProcessUnited StatesVaccinesVirulenceantimicrobialcombatdesignenzooticexperienceextracellulargene conservationgene productinsightlyme pathogenesismicrobialnovelnovel therapeutic interventionnovel therapeuticsnovel vaccinespathogenpathogenic bacteriapatient subsetspolypeptideprotein functionprotein protein interactionsmall moleculestandard caretick transmissiontick-bornetransmission processvaccine developmentvector tick
项目摘要
PROJECT SUMMARY/ABSTRACT
Lyme borreliosis, also known as Lyme disease, remains a prevalent tick-borne infection in many parts of the
world. In the United States alone, there are over 300,000 new cases occurring each year. The infection is
caused by Borrelia burgdorferi sensu lato, which is a group of atypical extracellular bacterial pathogens that
survive in nature through a complex enzootic infection cycle, involving ticks belonging to the Ixodes scapularis
complex and an array of vertebrate hosts, most commonly wild rodents. Despite serious efforts to control the
infection over the past several decades, the infection persists, largely due to the absence of effective control
measures against tick infestation, lack of human vaccines, difficulties in diagnosis of early infection, and clinical
complications associated with treatment using currently-available antimicrobials. Specifically, several months
after standard-care antibiotic therapy, a subset of patients can experience a series of persistent or relapsing
symptoms, known as chronic Lyme disease or post-treatment Lyme disease syndrome, for which further
treatment options remain unavailable. Therefore, the development of vaccines and new drugs is highly
warranted to combat Lyme disease. This project pursues a long-term goal to understand the biological
significance of a critical set of microbial virulence determinants and gain knowledge necessary for the
development of new therapeutic strategies to intervene with Lyme borreliosis. The emphasis is on protein-
protein interactions essential for pathogen infection and persistence in the host, and the goal is to provide
comprehensive structural and functional information that defines the biological significance of three spirochete
proteins annotated as BB0323, BB0238, and BB0104 (BbHtrA), each of which either independently or as a
complex are essential for infection. The previous project cycle demonstrated that the targeted deletion or
alteration of either protein partners or short binding epitopes impact protein stability and render the pathogen
non-infectious in a mammalian host. The overall objective of the current proposal is to further focus on
BB0323 and associated proteins in order to: 1) define the specific events of protein maturation, 2)
determine protein-protein interactions, and 3) contribute to the determination of their structures to
better understand their roles in dictating spirochete infection in mammals and transmission from ticks.
These studies will enlighten our fundamental knowledge of the atypical biology of spirochetes and will facilitate
the design of non-traditional anti-infective strategies to combat Lyme borreliosis, including the development of
vaccines, small molecule drugs, and biologics.
项目总结/文摘
项目成果
期刊论文数量(49)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
BBA52 facilitates Borrelia burgdorferi transmission from feeding ticks to murine hosts.
- DOI:10.1086/651172
- 发表时间:2010-04-01
- 期刊:
- 影响因子:0
- 作者:Kumar M;Yang X;Coleman AS;Pal U
- 通讯作者:Pal U
Characterization of spatial lipidomic signatures in tick-bitten guinea pig skin as a model for host-vector-pathogen interaction profiling.
- DOI:10.1128/msystems.00927-23
- 发表时间:2023-12-21
- 期刊:
- 影响因子:6.4
- 作者:
- 通讯作者:
A systemic approach to identify non-abundant immunogenic proteins in Lyme disease pathogens.
- DOI:10.1128/msystems.01087-23
- 发表时间:2024-01-23
- 期刊:
- 影响因子:6.4
- 作者:Yas, Ozlem Buyuktanir;Coleman, Adam S.;Lipman, Rachel M.;Sharma, Kavita;Raghunandanan, Sajith;Alanazi, Fuad;Rana, Vipin S.;Kitsou, Chrysoula;Yang, Xiuli;Pal, Utpal
- 通讯作者:Pal, Utpal
Function and evolution of the aquaporin IsAQP1 in the Lyme disease vector Ixodes scapularis
- DOI:10.1111/imb.12833
- 发表时间:2023-02-22
- 期刊:
- 影响因子:2.6
- 作者:Tsujimoto,Hitoshi;Metz,Hillery C. C.;Rasgon,Jason L. L.
- 通讯作者:Rasgon,Jason L. L.
BB0323 function is essential for Borrelia burgdorferi virulence and persistence through tick-rodent transmission cycle.
- DOI:10.1086/605846
- 发表时间:2009-10-15
- 期刊:
- 影响因子:0
- 作者:Zhang X;Yang X;Kumar M;Pal U
- 通讯作者:Pal U
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UTPAL PAL其他文献
UTPAL PAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UTPAL PAL', 18)}}的其他基金
Multivalent Tick-Microbe targeted Lyme disease vaccines
多价蜱微生物靶向莱姆病疫苗
- 批准号:
10442534 - 财政年份:2020
- 资助金额:
$ 48.67万 - 项目类别:
Multivalent Tick-Microbe targeted Lyme disease vaccines
多价蜱微生物靶向莱姆病疫苗
- 批准号:
10059039 - 财政年份:2020
- 资助金额:
$ 48.67万 - 项目类别:
Multivalent Tick-Microbe targeted Lyme disease vaccines
多价蜱微生物靶向莱姆病疫苗
- 批准号:
10219933 - 财政年份:2020
- 资助金额:
$ 48.67万 - 项目类别:
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens
跨物种免疫信号影响蜱传病原体的持久性
- 批准号:
9976334 - 财政年份:2018
- 资助金额:
$ 48.67万 - 项目类别:
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens
跨物种免疫信号影响蜱传病原体的持久性
- 批准号:
10222517 - 财政年份:2018
- 资助金额:
$ 48.67万 - 项目类别:
Cross-Species Immunity Signals Impacting Persistence of Tick-Borne Pathogens
跨物种免疫信号影响蜱传病原体的持久性
- 批准号:
10440407 - 财政年份:2018
- 资助金额:
$ 48.67万 - 项目类别:
BBA57-Mediated Borrelial Persistence, Genesis of Inflammation and Immunity
BBA57-介导的疏螺旋体持续存在、炎症和免疫的起源
- 批准号:
8996710 - 财政年份:2015
- 资助金额:
$ 48.67万 - 项目类别:
相似海外基金
Sustainable routes to anti-infective agents to combat future pandemics.
对抗未来流行病的抗感染药物的可持续途径。
- 批准号:
2775420 - 财政年份:2022
- 资助金额:
$ 48.67万 - 项目类别:
Studentship
Antibiotic K16: Elucidation and Engineering Pathways to New Anti-infective Agents.
抗生素 K16:新型抗感染药物的阐明和工程途径。
- 批准号:
BB/V008552/1 - 财政年份:2021
- 资助金额:
$ 48.67万 - 项目类别:
Research Grant
Medicinal Chemistry Optimisation of Novel Heterocyclic Anti-infective Agents
新型杂环抗感染药物的药物化学优化
- 批准号:
2599532 - 财政年份:2021
- 资助金额:
$ 48.67万 - 项目类别:
Studentship
Pathways to New Anti-infective Agents
新型抗感染药物的开发途径
- 批准号:
2449001 - 财政年份:2020
- 资助金额:
$ 48.67万 - 项目类别:
Studentship
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
管理核心 - 自噬调节剂作为新型广谱抗感染剂
- 批准号:
9893810 - 财政年份:2020
- 资助金额:
$ 48.67万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
10364721 - 财政年份:2019
- 资助金额:
$ 48.67万 - 项目类别:
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
管理核心 - 自噬调节剂作为新型广谱抗感染剂
- 批准号:
10364722 - 财政年份:2019
- 资助金额:
$ 48.67万 - 项目类别:
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
管理核心 - 自噬调节剂作为新型广谱抗感染剂
- 批准号:
10573255 - 财政年份:2019
- 资助金额:
$ 48.67万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
10573254 - 财政年份:2019
- 资助金额:
$ 48.67万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
9893808 - 财政年份:2019
- 资助金额:
$ 48.67万 - 项目类别: